StoryFirst seen

Anthropic starts its own drug discovery work alongside six partners

The move puts the AI lab in direct territory of the drug developers that buy its models.

Archived Updated

Everything it touches

2 names 3 voices 3 source posts

The story’s neighborhood

NAMESVOICESPOSTS

Explore the graph, or choose a connection below.

Follow the evidence

The source posts

This brief comes from Tech Twitter’s edited headlines. The posts below are the sources grouped with the story; statements in them belong to their authors.

AnthropicLead source
Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own. In doing so, we’ve learned much more about how Claude can support the many stages of drug development. In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences.
Read original on X
Just one day after filing for its IPO, Anthropic announces it’s getting into drug discovery ITSELF. so basically the AI company that sells tokens to an entire industry may eventually compete with its own customers.
Read original on X
Anthropic says it has started its own Claude-assisted drug discovery while partnering with six medicine makers, and it says early work has improved lab design, paperwork review and clinical planning.
Read original on X

How the headline evolved

  1. Anthropic starts its own drug discovery work alongside six partners

  2. Anthropic begins its own drug discovery work alongside six partners

  3. Anthropic starts its own drug discovery work alongside six partners

  4. Anthropic begins its own drug discovery work alongside partner research

Shared connections

Related stories